ATE250930T1 - Kataplasmen die steroide enthalten und deren herstellungsverfahren - Google Patents

Kataplasmen die steroide enthalten und deren herstellungsverfahren

Info

Publication number
ATE250930T1
ATE250930T1 AT99929738T AT99929738T ATE250930T1 AT E250930 T1 ATE250930 T1 AT E250930T1 AT 99929738 T AT99929738 T AT 99929738T AT 99929738 T AT99929738 T AT 99929738T AT E250930 T1 ATE250930 T1 AT E250930T1
Authority
AT
Austria
Prior art keywords
cataplasms
production process
blended
weight
crotamiton
Prior art date
Application number
AT99929738T
Other languages
English (en)
Inventor
Kazunori Hisamitsu Pharma Muta
Seiichiro Hisamitsu Phar Tsuru
Taro Hisamitsu Pharma Yamahata
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE250930T1 publication Critical patent/ATE250930T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT99929738T 1998-07-10 1999-07-07 Kataplasmen die steroide enthalten und deren herstellungsverfahren ATE250930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19593398A JP4456679B2 (ja) 1998-07-10 1998-07-10 ステロイド含有パップ剤及びその製造方法
PCT/JP1999/003673 WO2000002563A1 (fr) 1998-07-10 1999-07-07 Cataplasmes contenant des steroides et procede de fabrication associe

Publications (1)

Publication Number Publication Date
ATE250930T1 true ATE250930T1 (de) 2003-10-15

Family

ID=16349396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929738T ATE250930T1 (de) 1998-07-10 1999-07-07 Kataplasmen die steroide enthalten und deren herstellungsverfahren

Country Status (11)

Country Link
US (1) US6432431B1 (de)
EP (1) EP1097712B1 (de)
JP (1) JP4456679B2 (de)
KR (1) KR20010072664A (de)
CN (1) CN1308537A (de)
AT (1) ATE250930T1 (de)
BR (1) BR9912024A (de)
DE (1) DE69911788T2 (de)
ES (1) ES2209456T3 (de)
ID (1) ID27765A (de)
WO (1) WO2000002563A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3655781B2 (ja) * 1999-08-25 2005-06-02 帝國製薬株式会社 ビタミンｃ又はその誘導体を配合したパップ剤
JP5300038B2 (ja) * 2000-03-07 2013-09-25 株式会社 資生堂 皮膚外用剤
WO2001087244A1 (en) * 2000-05-15 2001-11-22 Hisamitsu Pharmaceutical Co., Inc. Sheet-type packs
CN1431906A (zh) * 2000-05-31 2003-07-23 日绊株式会社 透皮吸收型甾体外用药
CA2411950A1 (en) * 2000-06-13 2002-12-09 Hisamitsu Pharmaceutical Co., Inc. Patch
DE10260873A1 (de) * 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
US7988990B2 (en) * 2003-01-28 2011-08-02 Teikoku Seiyaku Co., Ltd. Thin aqueous cataplasm
EP1757309B1 (de) * 2004-04-28 2013-04-10 Hisamitsu Pharmaceutical Co., Inc. Klebematerial
JP4744439B2 (ja) * 2004-04-28 2011-08-10 久光製薬株式会社 貼付剤
JP4824337B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP4824336B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
CN103830179B (zh) * 2014-03-24 2015-11-18 段懿玲 一种含有克罗米通的外用制剂及其制备工艺
CN104984385B (zh) * 2015-07-23 2017-08-29 山东维赫生物科技有限公司 一种水溶性医用预粘剂
WO2019189756A1 (ja) * 2018-03-30 2019-10-03 ロート製薬株式会社 外用油性固形組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS58225009A (ja) * 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPH0236572B2 (ja) * 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6351330A (ja) * 1986-08-20 1988-03-04 Teikoku Seiyaku Kk ステロイド剤含有外用貼付剤
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPH0676327B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH05271077A (ja) * 1992-03-25 1993-10-19 Lion Corp パップ剤
JP3029964B2 (ja) * 1993-01-20 2000-04-10 久光製薬株式会社 ステロイド類溶解剤及びステロイド類を主剤とする外用液剤
JP2860748B2 (ja) 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JPH0853354A (ja) 1994-08-11 1996-02-27 Hisamitsu Pharmaceut Co Inc 皮膚疾患用水性貼付剤
KR970706805A (ko) * 1994-11-18 1997-12-01 나까토미 히로타카 경피흡수첩부제(percutaneously absorbable patch)

Also Published As

Publication number Publication date
EP1097712A4 (de) 2002-05-02
US6432431B1 (en) 2002-08-13
BR9912024A (pt) 2001-05-29
DE69911788D1 (de) 2003-11-06
ES2209456T3 (es) 2004-06-16
CN1308537A (zh) 2001-08-15
WO2000002563A1 (fr) 2000-01-20
JP2000026299A (ja) 2000-01-25
KR20010072664A (ko) 2001-07-31
ID27765A (id) 2001-04-26
EP1097712A1 (de) 2001-05-09
DE69911788T2 (de) 2004-05-06
JP4456679B2 (ja) 2010-04-28
EP1097712B1 (de) 2003-10-01

Similar Documents

Publication Publication Date Title
ATE250930T1 (de) Kataplasmen die steroide enthalten und deren herstellungsverfahren
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ES2117052T3 (es) Induccion de respuestas de linfocitos t citotoxicos.
ATE171871T1 (de) Fungizide zusammensetzungen enthaltend eine kombination von bifonazol und fluocinonid
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
ES2183945T3 (es) Composiciones para mejorar el aporte de un agente por electrotransporte.
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
BR0111630A (pt) Espiral para inseto
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
BR9908622A (pt) Composição farmacêutica à base de progesterona natural de sìntese e de estradiol, e seu processo de preparo
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
DE69908304D1 (de) Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
GR3034575T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
ES2059403T3 (es) Composicion util en el tratamiento de deficiencias de estrogenos.
BG106368A (en) Pharmaceutical composition and its preparation
DE59002738D1 (de) Kombinationspräparate enthaltend Chloramphenicol, Gentamicin und Nystatin als aktive Wirkstoffe zur topischen Behandlung entzündlicher Hauterkrankungen.
IT8148898A0 (it) Derivati steroidici 20-isonitrili 17(20)-insaturi,procedimento per laloro preparazione,e loro applicazione nella preparazione degli steroidi 17alfa-idrossi-20-chetonici
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
ZA969351B (en) Organic compositions
ATE271896T1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties